Uranium Royalty Corp. Consolidated Statements of Financial Position (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
Notes | As at April 30, 2022 ($) |
As at April 30, 2021 ($) |
||||||||||||||||
Assets |
||||||||||||||||||
Current Assets |
||||||||||||||||||
Cash |
4 | |||||||||||||||||
Restricted cash |
4 | |||||||||||||||||
Short-term investments |
5 | |||||||||||||||||
Inventories |
6 | |||||||||||||||||
Prepaids and other receivables |
||||||||||||||||||
Non-current Assets |
||||||||||||||||||
Right-of-use |
||||||||||||||||||
Royalties and royalty options |
7 | |||||||||||||||||
Liabilities |
||||||||||||||||||
Current Liabilities |
||||||||||||||||||
Accounts payable and accrued liabilities |
||||||||||||||||||
Current portion of lease liability |
||||||||||||||||||
Non-current Liabilities |
||||||||||||||||||
Government loan payable |
8 | |||||||||||||||||
Margin loan payable |
9 | |||||||||||||||||
Non-current portion of lease liability |
||||||||||||||||||
Equity |
||||||||||||||||||
Issued Capital |
10 | |||||||||||||||||
Reserves |
10 | |||||||||||||||||
Accumulated deficit |
( |
) | ( |
) | ||||||||||||||
Accumulated other comprehensive income |
||||||||||||||||||
/s/ “Neil Gregson” |
||
Neil Gregson Director |
/s/ “Vina Patel” |
||
Vina Patel Director |
Uranium Royalty Corp. Consolidated Statements of Loss and Other Comprehensive Income (Expressed in Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
For the year ended April 30, |
||||||||||
Notes | 2022 ($) |
2021 ($) |
||||||||
Expenses |
||||||||||
Depreciation |
||||||||||
Consulting fees |
||||||||||
Management and directors’ fees |
14 | |||||||||
Salaries, wages and benefits |
||||||||||
Uranium storage fee |
||||||||||
Investor communications and marketing expenses |
||||||||||
Office and technology expenses |
||||||||||
Transfer agent and regulatory fees |
||||||||||
Insurance fees |
||||||||||
Professional fees |
||||||||||
Write-off of royalty option |
7 | |||||||||
Share-based compensation |
||||||||||
Operating loss |
( |
) | ( |
) | ||||||
Other items |
||||||||||
Interest expense |
( |
) | ||||||||
Interest income |
||||||||||
Gain on sale of marketable securities |
||||||||||
Net foreign exchange loss |
( |
) | ( |
) | ||||||
Loss before taxes |
( |
) | ( |
) | ||||||
Deferred income tax recovery |
13 | |||||||||
Net loss for the year |
( |
) | ( |
) | ||||||
Other comprehensive income |
||||||||||
Items that will not subsequently be re-classified to net income: |
||||||||||
Unrealized gain on revaluation of short-term investments |
5 | |||||||||
Deferred tax expense on short-term investments |
5 | ( |
) | ( |
) | |||||
Item that may subsequently be re-classified to net income: |
||||||||||
Foreign currency translation differences |
( |
) | ||||||||
Total other comprehensive income for the year |
||||||||||
Total comprehensive income for the year |
||||||||||
Net loss per share, basic and diluted |
( |
) | ( |
) | ||||||
Weighted average number of shares, outstanding, basic and diluted |
|
|||||||||
Uranium Royalty Corp. Consolidated Statements of Changes in Equity (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
Notes | Number of Common Shares |
Issued Capital ($) |
Reserves ($) |
Accumulated Deficit ($) |
Accumulated Other Comprehensive Income ($) |
Total ($) |
||||||||||||||||||||
Balance at April 30, 2020 |
( |
) | ||||||||||||||||||||||||
Common shares issued upon exercise of warrants |
( |
) | — | — | ||||||||||||||||||||||
Transfer of gain on disposal of short-term investments at fair value through other comprehensive income to accumulated deficit |
— | — | — | ( |
) | — | ||||||||||||||||||||
Net loss for the year |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||||
Total other comprehensive loss |
— | — | — | — | ||||||||||||||||||||||
|
||||||||||||||||||||||||||
Balance at April 30, 2021 |
( |
) | ||||||||||||||||||||||||
Common shares issued upon exercise of warrants |
( |
) | — | — | ||||||||||||||||||||||
Common shares issued upon exercise of options |
( |
) | — | — | ||||||||||||||||||||||
Common shares issued to acquire royalties |
7 | — | — | — | ||||||||||||||||||||||
Public offering: |
||||||||||||||||||||||||||
Common shares issued for cash |
10 | — | — | — | ||||||||||||||||||||||
Underwriters’ fees and issuance costs |
10 | — | ( |
) | — | — | — | ( |
) | |||||||||||||||||
At-the-Market |
||||||||||||||||||||||||||
Common shares issued for cash |
10 | — | — | — | ||||||||||||||||||||||
Agents’ fees and issuance costs |
10 | — | ( |
) | — | — | — | ( |
) | |||||||||||||||||
Share-based compensation |
10 | — | — | — | — | |||||||||||||||||||||
Net loss for the year |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||||
Total other comprehensive income |
— | — | — | — | ||||||||||||||||||||||
|
||||||||||||||||||||||||||
Balance at April 30, 2022 |
( |
) | ||||||||||||||||||||||||
|
Uranium Royalty Corp. Consolidated Statements of Cash Flows (Expressed in Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
For the year ended April 30, | ||||||||
2022 ($) |
2021 ($) |
|||||||
Operating activities |
||||||||
Net loss before tax for the year |
( |
) | ( |
|||||
Adjustments for: |
||||||||
Depreciation |
||||||||
Interest expense |
||||||||
Interest income |
( |
) | ( |
|||||
Gain on sale of marketable securities |
( |
) | ||||||
Share-based compensation |
||||||||
Write-off of royalty option |
||||||||
Net foreign exchange loss |
||||||||
Net changes in non-cash working capital items: |
||||||||
Inventories |
( |
) | ( |
|||||
Prepaids and other receivables |
( |
) | ||||||
Accounts payable and accrued liabilities |
( |
) | ||||||
Cash used in operating activities |
( |
) | ( |
|||||
Investing activities |
||||||||
Investment in royalties and royalty options |
( |
) | ||||||
Interest received |
||||||||
Net proceeds from sale of marketable securities |
||||||||
Investment in short-term investments |
( |
) | ( |
|||||
Cash generated from (used in) investing activities |
( |
) | ||||||
Financing activities |
||||||||
Proceeds from public offering, net of underwriters’ fees and issuance costs |
||||||||
Proceeds from At-the-Market |
||||||||
Proceeds from common shares issued upon exercise of options and warrants |
||||||||
Net proceeds from margin loan payable |
||||||||
Payments of lease liability |
( |
) | ||||||
Interest and fees paid |
( |
) | ||||||
Cash generated from financing activities |
||||||||
Effect of exchange rate changes on cash |
( |
) | ( |
|||||
Net decrease in cash |
( |
) | ( |
|||||
Cash |
||||||||
Beginning of year |
||||||||
End of year |
||||||||
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
1. |
Corporate Information |
2. |
Basis of Preparation |
2.1 |
Statement of compliance |
2.2 |
Basis of presentation |
2.3 |
Basis of consolidation |
3. |
Significant Accounting Policies |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
3. |
Significant Accounting Policies (continued) |
● | where the deferred income tax liability arises from the initial recognition of goodwill or of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and |
● | in respect of taxable temporary differences associated with investments in subsidiaries, where the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future. |
● | where the deferred income tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
3. |
Significant Accounting Policies (continued) |
● | in respect of deductible temporary differences associated with investments in subsidiaries, deferred income tax assets are recognized only to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized. |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
3. |
Significant Accounting Policies (continued) |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
3. |
Significant Accounting Policies (continued) |
• | The Company’s business is the acquisition of royalties. Each royalty has its own unique terms and judgement is required to assess the appropriate accounting treatment. The assessment of whether an acquisition meets the definition of a business or whether assets are acquired is an area of judgement. In evaluating whether a transaction is a business combination management must consider if the acquired assets or entities encompass an integrated set of activities and assets that is capable of being conducted and managed for the purpose of generating income. Additionally, an optional asset concentration test may be applied. If deemed to be a business combination, applying the acquisition method to business combinations requires each identifiable asset and liability to be measured at its acquisition date fair value. The excess, if any, of the fair value of the consideration over the fair value of the net identifiable assets acquired is recognized as goodwill. |
● |
The Company estimates the attributable reserve and resource relating to the mineral properties underlying the royalties that are held by the Company. Reserves and resources are estimates of the amount of minerals that can be economically and legally extracted from the mining properties at which the Company has royalty interests, adjusted where applicable to reflect the Company’s percentage entitlement to minerals produced from such mines. The public disclosures of reserves and resources that are released by the operators of the interests involve assessments of geological and geophysical studies and economic data and the reliance on a number of assumptions, including commodity prices and production costs. The estimates of reserves and resources may change based on additional knowledge gained subsequent to the initial assessment. Changes in the reserve or resource estimates may impact the carrying value of the Company’s royalty interests. |
● |
The assessment of impairment of royalty and other interests requires the use of judgments, assumptions and estimates when assessing whether there are any indicators that could give rise to the requirement to conduct a formal impairment test as well as in the assessment of fair values. When assessing whether there are indicators of impairment, management uses its judgment in evaluating the indicators such as significant changes in future commodity prices, discount rates, foreign exchange rates, taxes, operator reserve and resource estimates or other relevant information received from the operators that indicates production from royalty interests will not likely occur or may be significantly reduced in the future. In addition, the Company may use other approaches in determining fair value which may include estimates related to (i) dollar value per unit of mineral reserve/resource; (ii) cash-flow multiples; (iii) comparable transactions and (iv) market capitalization of comparable companies. Changes in any of the estimates used in determining the fair value of the royalty and other interests could impact the impairment analysis. |
● |
The Company continues to closely monitor the ongoing COVID-19 pandemic. The COVID-19 pandemic and related restrictions and supply chain disruptions may impact the operators of the projects underlying the Company’s interests, including by resulting in delays in planned exploration and development activities and production delays or suspensions. To date, certain operators of the projects in which the Company holds interests have announced impacts to the operations underlying the Company’s interests. Given the nature of the Company’s operations, the pandemic has, to date, had relatively little direct impact on the Company’s day-to-day operations. However, restrictions and measures instituted by various governments around the world have reduced the ability of the Company’s personnel and advisors to travel and visit projects in connection with the review of potential acquisitions. |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
4. |
Cash and Restricted Cash |
As at April 30, 2022 ($) |
As at April 30, 2021 ($) |
|||||||||||
Cash at bank |
||||||||||||
5. |
Short-term Investments |
As at April 30, 2022 ($) |
As at April 30, 2021 ($) |
|||||||||
Fair value, at the beginning of the year |
||||||||||
Additions for the year |
||||||||||
Disposals for the year |
( |
) | ( |
) | ||||||
Fair value adjustment due to foreign exchange rate change for the year | ( |
) | ( |
) | ||||||
Fair value adjustment due to share price change for the year |
||||||||||
Fair value, at the end of the year |
||||||||||
6. |
Inventories |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
7. |
Royalties and Royalty Options |
Royalties ($) |
Royalty Options ($) |
Total ($) |
||||||||||||||
Balance, as at April 30, 2020 |
||||||||||||||||
Foreign currency translation |
( |
) | ( |
) | ||||||||||||
Balance, as at April 30, 2021 |
||||||||||||||||
Additions |
||||||||||||||||
Foreign currency translation |
||||||||||||||||
Write-off |
( |
) | ( |
) | ||||||||||||
Balance, as at April 30, 2022 |
As at April 30, 2022 ($) |
As at April 30, 2021 ($) |
|||||||||||
Anderson project |
||||||||||||
Church Rock project |
||||||||||||
Cigar Lake project |
— | |||||||||||
Dawn Lake project |
— | |||||||||||
Dewey-Burdock project |
||||||||||||
Diabase project |
— | |||||||||||
Lance project |
||||||||||||
Langer Heinrich project |
||||||||||||
McArthur River project |
— | |||||||||||
Michelin project |
||||||||||||
Reno Creek project |
||||||||||||
Roca Honda project |
||||||||||||
Roughrider project |
||||||||||||
Slick Rock project |
||||||||||||
Workman Creek project |
||||||||||||
Total |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
7. |
Royalties and Royalty Options (continued) |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
8. |
Government Loan Payable |
9. |
Margin Loan Payable |
US$000 | $ | |||||||||||
Draw-down |
||||||||||||
Less: transaction costs |
( |
) |
( |
) |
||||||||
Interest expense |
||||||||||||
Interest and fees paid |
( |
) |
( |
) |
||||||||
Unrealized foreign exchange loss |
— |
|||||||||||
Balance, as at April 30, 2022 |
10. |
Issued Capital |
10.1 |
Common Shares |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
10. |
Issued Capital (continued) |
10.1 |
Common Shares (continued) |
Number of Common Shares |
||||
Common shares issued at $ |
10.2 |
Reserves |
Warrants ($) |
Share Options ($) |
Total ($) |
||||||||||||||
Balance, as at April 30, 2020 |
— | |||||||||||||||
Common shares issued upon exercise of warrants |
( |
) | — | ( |
) | |||||||||||
Balance, as at April 30, 2021 |
— | |||||||||||||||
Common shares issued upon exercise of warrants |
( |
) | — | ( |
) | |||||||||||
Common shares issued upon exercise of options |
— | ( |
) | ( |
) | |||||||||||
Share-based compensation |
— | |||||||||||||||
Balance, as at April 30, 2022 |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
10. |
Issued Capital (continued) |
10.2 |
Reserves (continued) |
|
|
|
||||||
Number of options |
Weighted Average Exercise Price ($) |
|||||||
|
|
|
||||||
Balance at April 30, 2021 |
||||||||
Granted |
||||||||
Forfeited |
( |
) | ||||||
Exercised |
( |
) | ||||||
|
|
|
||||||
Balance at April 30, 2022 |
||||||||
|
|
|
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
10. |
Issued Capital (continued) |
10.2 |
Reserves (continued) |
|
||||
Risk-free interest rate |
% | |||
Expected life (years) |
||||
Expected volatility |
% | |||
Expected dividend yield |
% | |||
Estimated forfeiture rate |
% | |||
|
|
|
| ||||||||||||||
Options Outstanding | Options Exercisable | |||||||||||||||
|
|
| ||||||||||||||
Exercise Price ($) |
Number of Options Outstanding |
Weighted Average Exercise Price ($) |
Weighted Average Remaining Contractual Life (years) |
Number of Options Exercisable |
Weighted Average Exercise Price ($) |
Weighted Average Remaining Contractual Life (years) | ||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
|
|
|
|
| |||||||||||
|
|
|
|
|
|
|
10.3 |
Long Term Incentive Plan |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
10. |
Issued Capital (continued) |
10.3 |
Long Term Incentive Plan (continued) |
12. |
Financial Instruments |
● | Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities. |
● | Level 2: other techniques for which all inputs have a significant effect on the recorded fair value which are observable, either directly or indirectly. |
● | Level 3: techniques which use inputs that have a significant effect on the recorded fair value that are not based on observable market data. |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
12. |
Financial Instruments (continued) |
12.1 |
Financial risk management objectives and polices |
12.2 |
Credit risk |
12.3 |
Liquidity risk |
12.4 |
Commodity price risk |
12.5 |
Interest rate risk |
12.6 |
Currency risk |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
12. |
Financial Instruments (continued ) |
12.7 |
Other price risk |
13. |
Income Tax |
For the year ended April 30, |
||||||||
2022 ($) |
2021 ($) |
|||||||
Net loss before tax for the year |
||||||||
Statutory rate |
% | % | ||||||
Recovery of income taxes at statutory rates |
||||||||
Non-deductible permanent differences |
( |
) | ( |
|||||
Change in unrecognized deferred income tax assets |
||||||||
Other |
|
|||||||
Tax recovery for the year |
|
|||||||
As at April 30, 2022 ($) |
As at April 30, 2021 ($) |
|||||||||
Deferred tax liabilities: |
||||||||||
Excess of accounting value of short-term investments over tax value |
( |
( |
) | |||||||
Deferred tax assets: |
||||||||||
Non-capital losses carry-forward |
||||||||||
|
||||||||||
As at April 30, 2022 ($) |
As at April 30, 2021 ($) |
|||||||||
Non-capital loss carry-forward |
||||||||||
Financing costs |
|
|
||||||||
Unrecognized deferred income tax assets |
||||||||||
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
14. |
Related Party Transactions |
14.1 |
Related Party Transactions |
14.2 |
Transactions with Key Management Personnel |
For the year ended April 30, | ||||||||||
2022 ($) |
2021 ($) |
|||||||||
Management salaries |
|
|
||||||||
Directors’ fees |
||||||||||
Share-based compensation |
||||||||||
Total |
15. |
Operating Segments |
16. |
Commitments |
Uranium Royalty Corp. Notes to Consolidated Financial Statements (Expressed in thousands of Canadian dollars unless otherwise stated) |
URANIUM ROYALTY CORP |
17. |
Subsequent Events |